Mednax receives consensus rating of “buy”: 5 things to know

Mednax shares have received a consensus recommendation of “buy” from the 12 ratings firms that are currently covering the firm, according to a Storm Investor report.

Advertisement

Here are five things to know:

1. The average one-year price objective for the stock is $83.40.

2. Mednax has a market cap of $6.78 billion.

3. The firm has a one-year low of $64.12 and a one-year high of $86.09.

4. The company’s 50-day moving average is $72.11 and its 200-day moving average is $76.93.

5. Mednax provides anesthesia care at more than 90 hospitals and over 100 ambulatory surgery centers and office-based practices.

More articles on anesthesia:
National Health Council names ASA CEO Paul Pomerantz treasurer: 3 points
Weill Cornell Medical College names Dr. Sheida Tabaie the anesthesia department’s Global Health Fellow: 4 points
A kidney donor death highlights the dangers of anesthesia — 4 things to know

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.